The objective of this study was to understand pain treatment utilization, perceived efficacy,
and differences in utilization by gender, clinic site, chronicity of pain, pain severity, and …

Objectives Significant pain from HIV‐associated sensory neuropathy (HIV‐SN) affects 40%
of HIV‐infected individuals treated with antiretroviral therapy (ART). The most salient …

Background: A recent meta-analysis affirmed the benefit of medicinal cannabis for chronic
neuropathic pain, a disabling and difficult-to-treat condition. As medicinal cannabis use is …

Introduction We studied the evolution of sensory neuropathy after antiretroviral therapy
(ART) in human immunodeficiency virus–infected South Africans. Methods Enrolment …

HIV-associated sensory neuropathy (HIV-SN) is a common complication of HIV and remains
highly prevalent even with modern HIV management strategies, causing debilitating pain in …

Neuropathic pain is a disabling condition caused by various diseases and can profoundly
impact the quality of life. Unfortunately, current treatments often do not produce complete …

With the introduction of combination antiretroviral therapy, human immunodeficiency virus
(HIV)-infected individuals are living longer, and are commonly confronted with chronic …

Painful distal symmetrical polyneuropathy is common in HIV and is associated with reduced
quality of life. Research has not explored the experience of neuropathic pain in people with …

Several drugs and agents are currently used for the treatment of neuropathic pain. Among
them amitriptyline, a tricyclic antidepressant drug, represent a first line treatment. Despite its …

Pain affects over half of the people living with HIV/AIDS (LWHA), and pharmacological
treatment has limited efficacy. Preliminary evidence supports nonpharmacological …